Pepsi says people are skipping meals — and it's great for business

• PepsiCo says the impact of weight-loss drugs on its sales has so far been "negligible."
• Instead, the food and beverage giant is seeing "meals becoming more mini-meals."
• Analysts say companies will have plenty of time to prepare for the impact of weight-loss drugs.

PepsiCo is the latest food corporation to weigh in on the sales impact of weight-loss drugs like Ozempic and Wegovy, telling analysts Tuesday the effect has so far been "negligible."